ESC 365 - Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

ESC Premium Access

Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Session: The right glucose-lowering drugs for the right patient

Topic: Epidemiology

Speaker: Doctor M. Elmegaard (Copenhagen, DK)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Mariam Elmegaard

Gentofte University Hospital, Copenhagen (Denmark)

0 follower

3 more presentations in this session

State of the Art in antidiabetic treatment to prevent CVD

Speaker: Professor A. Norhammar (Stockholm, SE)

Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study

Speaker: Mrs M. Fangel (Aalborg, DK)

Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus

Speaker: Doctor D. Berg (Boston, US)

Access the full session

The right glucose-lowering drugs for the right patient

Speakers: Doctor M. Elmegaard, Professor A. Norhammar, Mrs M. Fangel, Doctor D. Berg

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources